Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MARA vs GSK✓SelectedUSD · GSKMARA vs GSK performance historyLatest closeAs of-18.56%11/20
Stock and ETF performance explorer

MARA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-52.2%
GSK return
+53.4%
Excess return
-105.5%
Maximum drawdown
-83.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-18.6%-0.1%-18.4%-18.6%
7D-27.2%-5.3%-21.8%-27.6%
30D-34.7%-3.7%-31.0%-34.8%
3M-54.3%-7.3%-47.1%-54.5%
6M-61.3%-4.2%-57.1%-61.4%
YTD-43.3%+0.9%-44.2%-43.2%
1Y-50.3%+7.3%-57.6%-50.3%
3Y-52.2%+52.7%-104.9%-58.8%
All-52.2%+53.4%-105.5%-58.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling